Top Clinical Trials companies in Israel by Net Cash Used Provided By Financing Activities

This ranking features the top 17 Clinical Trials companies in Israel ranked by Net Cash Used Provided By Financing Activities, totaling a Net Cash Used Provided By Financing Activities of USD 123.39 M, for February 05, 2025.
#
Name
Net Cash Used Provided By Financing Activities
Reported Date
Stock Price
Change
Price (30 days) Country
1
USD 22.92 M
Dec. 31, 2023 USD 19.58 -1.51%

Israel

2
USD 22.68 M
Dec. 31, 2023 USD 6.90 -0.18%

Israel

3
USD 15.06 M
Dec. 31, 2023 USD 0.01 -0.18%

Israel

4
USD 9.98 M
Dec. 31, 2023 USD 2.86 -4.35%

Israel

5
USD 9.14 M
Dec. 31, 2023 USD 0.01 -0.18%

Israel

6
USD 8.84 M
June 30, 2024 USD 4.42 -0.18%

Israel

7
USD 6.04 M
Dec. 31, 2023 USD 2.19 -6.01%

Israel

8
USD 5.45 M
Dec. 31, 2023 USD 0.02 -0.18%

Israel

9
USD 5.30 M
Dec. 31, 2023 USD 3.70 -2.63%

Israel

10
USD 4.62 M
Dec. 31, 2023 USD 3.12 -5.74%

Israel

11
USD 3.90 M
Dec. 31, 2023 USD 1.11 4.72%

Israel

12
USD 3.50 M
Dec. 31, 2023 USD 2.04 NA

Israel

13
USD 3.08 M
Dec. 31, 2023 USD 2.33 -0.18%

Israel

14
USD 2.38 M
Dec. 31, 2023 USD 0.11 -0.18%

Israel

15
USD 896.46 K
Dec. 31, 2023 USD 1.88 -0.18%

Israel

16
USD 360.00 K
Dec. 31, 2023 USD 1.10 -0.18%

Israel

17
USD -738.93 K
Dec. 31, 2023 USD 0.08 -1.82%

Israel

Frequently Asked Questions
  • Which Clinical Trials company in Israel has the highest Net Cash Used Provided By Financing Activities ?

    The Clinical Trials company in Israel with the highest Net Cash Used Provided By Financing Activities is MediWound Ltd. (NasdaqGM: MDWD) at USD 22.92 M.

  • Which Clinical Trials company in Israel has the lowest Net Cash Used Provided By Financing Activities ?

    The Clinical Trials company in Israel with the lowest Net Cash Used Provided By Financing Activities is Bio-View Ltd (Tel Aviv Stock Exchange: BIOV.TA) at USD -738.93 K.

SV Wall Street